PDF(814 KB)
槲皮素与5-氨基水杨酸协同治疗感染后肠易激综合征大鼠的药效机制
张玉春, 左晓, 邵云云, 饶志, 武新安, 秦红岩
中国医院药学杂志 ›› 2016, Vol. 36 ›› Issue (23) : 2054-2058.
PDF(814 KB)
PDF(814 KB)
槲皮素与5-氨基水杨酸协同治疗感染后肠易激综合征大鼠的药效机制
Synergistic effects and underlying mechanism of quercetin and 5-aminosalicylic acid on post-infactious irritable bowel syndrome in rats
目的：研究槲皮素与5-氨基水杨酸（5-ASA）对感染后肠易激综合征（PI-IBS）的治疗作用及其机制。方法：PI-IBS大鼠模型分别灌胃给予5-ASA、槲皮素或5-ASA联合槲皮素，连续给药2周。腹壁收缩实验测定内脏痛阈值，水应激法评价结肠运动；收集血液和结肠，液质联用法测定5-ASA及其代谢物N-乙酰-5-ASA含量。结果：与正常组相比，PI-IBS组内脏痛阈值显著降低，结肠排便增多（P<0.05）。与模型组相比，5-ASA联合槲皮素可显著提高PI-IBS大鼠内脏痛阈值并明显减少结肠排便数量，其作用优于各单独用药组。槲皮素可明显增加PI-IBS大鼠结肠5-ASA含量并显著降低N-乙酰-5-ASA含量（P<0.05）。结论：槲皮素联合5-ASA对PI-IBS大鼠具有协同治疗作用，其机制可能与槲皮素抑制5-ASA代谢酶，提高结肠5-ASA浓度从而增强其治疗效果有关。
OBJECTIVE To investigate therapeutic effects and mechanism of quercetin and 5-aminosalicylic acid (5-ASA) on post-infectious irritable bowel syndrome (PI-IBS) in rats.METHODS PI-IBS rats were orally administered 5-ASA, quercetin or 5-ASA plus quercetin, respectively. Drugs were given to rats for 2 weeks consecutively. After treatment, visceral pain threshold pressure was measured by abdominal withdrawal reflex test, while colonic transit was evaluated by water avoidance stress test in PI-IBS rats. Then blood samples and colon tissues were collected for determination of concentrations of 5-ASA and its metabolite N-acetyl-5-ASA (N-AC-5-ASA) by LC-MS/MS method.RESULTS Compared to normal rats, PI-IBS rats presented significantly reduced visceral pain threshold pressure and increased fecal pellet output (P<0.05). Compared to PI-IBS model rats, pain threshold pressure was markedly increased, while fecal pellet output was significantly reduced in rats treated with 5-ASA in combination with quercetin, and this therapeutic effect was superior to that of rats treated with 5-ASA or quercetin only. Moreover, quercetin treatment significantly increased content of 5-ASA but markedly reduced content of N-AC-5-ASA in colon tissues of PI-IBS rats (P<0.05).CONCLUSION Synergistic therapeutic effects are observed in PI-IBS rats treated with 5-ASA in combination with quercetin, and underlying mechanism may be correlated with inhibitory effects of quercetin on 5-ASA metabolic enzyme, which increases colonic concentration of 5-ASA, and thus improves therapeutic effects of 5-ASA in PI-IBS rats.
感染后肠易激综合征 / 槲皮素 / 5-氨基水杨酸 / 内脏痛敏 {{custom_keyword}} /
post-infectious irritable bowel syndrome / quercetin / 5-aminosalicylic acid / visceral hyperalgesia {{custom_keyword}} /
[1] Spiller R, Garsed K. Postinfectious irritable bowel syndrome[J]. Gastroenterology, 2009, 136(6): 1979-1988.
[2] Gasbarrini A, Lauritano EC, Garcovich M, et al. New insights into the pathophysiology of IBS: intestinal microflora, gas production and gut motility[J]. Eur Rev Med Pharmacol Sci, 2008, 12(1): 111-117.
[3] Corinaldesi R, Stanghellini V, Cremon C, et al. Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome:a randomized controlled proof-of-concept study[J]. Aliment Pharmacol Ther, 2009, 30(3): 245-252.
[4] Dorofeyev AE, Kiriyan EA, Vasilenko IV, et al. Clinical,endoscopical and morphological efficacy of mesalazine in patients with irritable bowel syndrome[J]. Clin Exp Gastroenterol, 2011, 4: 141-153.
[5] Crozier A, Jaganath IB, Clifford MN. Dietary phenolics: chemistry, bioavailability and effects on health[J]. Nat Prod Rep, 2009, 26(8): 1001-1043.
[6] Kukongviriyapan V, Phromsopha N, Tassaneeyakul WA, et al. Inhibitory effects of polyphenolic compounds on human arylamine N-acetyltransferase 1 and 2[J]. Xenobiotica, 2006, 36(1): 15-28.
[7] Qin HY, Xiao HT, Wu JC, et al. Key factors in developing the trinitrobenzene sulfonic acid-induced post-inflammatory irritable bowel syndrome model in rats[J]. World J Gastroenterol, 2012, 18(20): 2481-2492.
[8] Al-chaer ED, Kawasaki M, Pasricha PJ. A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development[J]. Gastroenterology, 2000, 119(5): 1276-1285.
[9] Bonaz B, Tache Y. Water-avoidance stress-induced C-fos expression in the rat-brain and stimulation of fecal output-role of corticotropin-releasing factor[J]. Brain Res, 1994, 641(1): 21-28.
[10] 饶志,秦红岩,邵云云,等.液相色谱-质谱联用方法测定大鼠血浆,尿液及结肠组织中美沙拉嗪及其代谢产物N-乙酰-5-ASA的浓度[J].中国药学杂志,2014,49(14):1252-1257.
[11] Halliwell B, Zhao KC, Whiteman M. The gastrointestinal tract: A major site of antioxidant action?[J]. Free Radic Res, 2000, 33(6): 819-830.
国家自然科学青年基金项目（81400596），甘肃省卫生行业科研计划管理基金项目（GWGL2013-25）
/
| 〈 |
|
〉 |
